ArticleFrontiers in bioengineering and biotechnology2025
A machine learning model for assessing fetal health during pregnancy.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a global imperative to end stillbirths, particularly in low middle income countries (LMICs), which suffer from disproportionate incidence. Sudden changes in fetal movement (FM) patterns often precede a crisis, which, if flagged, can trigger life-saving intervention. Existing means of FM tracking, however, are based on outdated understanding which have remained unchanged for decades. The current standard for monitoring FM out-of-clinic remains maternal perception, which suffers from subjectivity and has little impact in reducing stillbirth or poor perinatal outcomes. Ultrasound can trace FM and trigger intervention but is administered sporadically over the course of pregnancy and demands clinician expertise and resources; frequent use is not feasible, particularly in LMICs. Wearable FM monitors have been proposed for FM empirical movement monitoring, however, clinical impact remains negligible due to homogeneous sensing modalities and lack of clinical validation. Herein, a multimodal vibrational-acoustic sensor array consisting of piezoelectric and acoustic sensing modalities is validated for use in a wearable FM. 25 pregnant participants were recruited to record vibrational-acoustic data from the array in parallel with ultrasound scanning. Categorised fetal movements were recorded by a clinician, and several machine learning models were investigated to validate the sensors to track FM. An ensemble RUSBoost model combined with concatenated sensor data inputs was implemented, yielding FM prediction with precision and recall of 0.44 and 0.61, demonstrating the feasibility of the vibroacoustic sensor array to monitor FM. Inexpensive off-the-shelf sensors comprising the array provide a basis for the development of a fully wearable FM monitor that can be used in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.